申请人:HOFFMANN LA ROCHE
公开号:WO2012163724A1
公开(公告)日:2012-12-06
The present invention relates to the use of novel triazolopyridine derivatives of formula I: wherein all variable substituents are defined as described herein, which are SYK inhibitors and are useful for the treatment of auto-immune and inflammatory diseases.
本发明涉及使用以下式I的新型三唑
吡啶衍生物:其中所有变量取代基的定义如本文所述,这些衍
生物是SYK
抑制剂,可用于治疗自身免疫和炎症性疾病。